IHME participated in the three-day, invitation only Malaria Forum entitled “Optimism and Urgency,” hosted by the Bill & Melinda Gates Foundation in Seattle, WA.

Dr. Christopher J.L. Murray, Director of IHME and Professor of Global Health, participated on the "Estimating Malaria Burden and Impact" panel on Wednesday, October 19. Panelists discussed how different modeling approaches produce different malaria burden estimates and inform the discussion of malaria control and eradication.

The panel, moderated by Allan Saul, Chief Executive Officer, Novartis Vaccine Institute for Global Health, also included Roy Anderson, Professor of Infectious Disease Epidemiology, Imperial College London, Nathan Myhrvold, Founder, Intellectual Ventures/Global Good, and Marcel Tanner, Professor and Director, Swiss Tropical & Public Health Institute.

IHME Post-Graduate Fellow, Tom Achoki, also presented a poster with findings from the first phase of IHME’s Malaria Control Policy Assessment (MCPA) project in Zambia.

The forum brought together global health leaders and malaria experts from around the world, including the director-general of the World Health Organization, leaders in public and private malaria programs throughout Africa, and key drug industry officials.